Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer globally. Over 90% of HCC cases arise in the context of liver cirrhosis, and the severity of the underlying liver ... Screening ...

Non-alcoholic fatty liver ... Doppler ultrasound scans. The SAF score was employed to semi-quantify each individual feature of NAFLD, encompassing steatosis, inflammatory activity, and fibrosis, in ...

Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.

Where multiple sensitivity and specificity values are reported, the values providing the highest Youden Index are given (i.e., highest sum of sensitivity and specificity minus one). ALT: Alanine ...

In the recent years, there have been an increasing number of reports on favourable effects of statins in patients with advanced chronic liver disease. These include reduction in portal pressure, ...

Bioartificial liver support systems, granulocyte-colony stimulating factors or stem-cell transplant are in the horizon of medical care of this patient population; however, data are too premature to ...

Roche’s Genentech unit bought Jecure Therapeutics and its portfolio of NLRP3 drugs in 2018, focusing on peripheral drugs for NASH, liver fibrosis, gout, inflammatory bowel disease, and ...